What products are there in the human insulin market?

It seems that people nowadays are paying more and more attention to human insulin. With the development of society, there are more and more human insulin on the market. Bayer will launch a new human insulin-Zhonghelin recently. Chonghelin (recombinant human insulin) is an insulin which is completely consistent with human insulin structure and is biosynthesized by using genetic engineering technology with Escherichia coli as the host. The production of Chonghelin is completely carried out under the EU GMP standard, which is the strictest drug production and quality management system in the world. Compared with the China Pharmacopoeia standard, its index control is stricter. The production technology of Zhonghelin has two patents in 58 countries, including the United States, the European Union and China.